Although the mechanisms how changing from daily DPP4 inhibitors to weekly OMG causes beneficial effect in liver with NAFLD/NASH are unclear, decreasing effect of OMG on inflammation and insulin resistance probably in liver might be involved. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.